RossDouglasCranstonMD

Infectious Disease • Pittsburgh, PA

Assistant Professor, Medicine, University of Pittsburgh School of Medicine

Join to view full profile

Are you Dr. Cranston?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 10 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
3520 5th Ave

Pittsburgh, PA 15213
Phone+1 412-383-2054

Summary

Dr. Ross Cranston, MD is an infectious disease specialist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with UPMC Magee-Womens Hospital and is an Assistant Professor at University of Pittsburgh School of Medicine.

Education & Training

Medical School, University of EdinburghClass of 1990

Certifications & Licensure

PA State Medical License 2007 - 2016

Clinical Trials

Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability Start of enrollment: 2006 Sep 01
Completed
Rectal Safety and Acceptability Study of Tenofovir 1% Gel Start of enrollment: 2010 Oct 01
Completed
Phase 1
Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures Start of enrollment: 2011 Mar 01
Completed
Phase 1
Anal Human Papillomavirus in Inflammatory Bowel Disease Study Start of enrollment: 2011 Jun 01
Completed
Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women Start of enrollment: 2012 Mar 01
Completed
Phase 3
Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel Start of enrollment: 2013 Sep 25
Completed
Phase 2
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV Start of enrollment: 2013 Dec 04
Completed
Not Applicable
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials Start of enrollment: 2013 Sep 01
Completed
Join now to see all

Publications & Presentations

PubMed

4 citations
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.
Silvia Bernal, Maria C Puertas, Sara Morón-López, Ross D Cranston, Víctor Urrea
The Journal of Infectious Diseases. 2023-11-02
Short-term effectiveness and tolerability of carbon dioxide laser for anal high-grade squamous intraepithelial lesions in individuals living with HIV.
Irene Fuertes, Iván Chivite, Ross D Cranston, Emilia Sánchez, Encarna Cordón
International Journal of STD & AIDS. 2022-06-01
9 citations
An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate.
Ian McGowan, Ratiya Pamela Kunjara Na Ayudhya, Rhonda M. Brand, Mark A. Marzinke, Craig W. Hendrix
AIDS Research and Human Retroviruses. 2021-10-29